科兴制药: 独立董事专门会议工作制度

Core Viewpoint - The company aims to enhance its corporate governance by improving the board structure and protecting the interests of minority shareholders and stakeholders through the establishment of a set of regulations for independent directors [1][2]. Group 1: Independent Director Definition and Responsibilities - Independent directors are defined as those who do not hold any position other than as a director or committee member and have no direct or indirect interests that could affect their independent judgment [2]. - Independent directors have a duty of loyalty and diligence to the company and all shareholders, and they must fulfill their responsibilities according to laws, regulations, and the company's articles of association [2][3]. Group 2: Meetings and Decision-Making - The company is required to hold independent director meetings at least once a year, with special meetings called as needed, ensuring all independent directors are notified in advance [4][5]. - Decisions made in independent director meetings require a majority agreement from all independent directors and must be documented, including the basis for opinions and the legality of discussed matters [4][5][6]. Group 3: Special Powers and Responsibilities - Independent directors have specific powers that require majority approval in their meetings, including hiring external consultants for audits or proposals to convene shareholder meetings [5][6]. - Independent directors must maintain confidentiality regarding meeting discussions and are responsible for signing off on meeting records [6]. Group 4: Implementation and Compliance - The regulations will take effect upon approval by the company's board and will be modified as necessary to comply with national laws and the company's articles of association [6]. - The board of directors holds the authority to interpret these regulations [6].